Regarding the diagnosis and antimicrobial management of enteric fever in India, all of the following statements are correct EXCEPT:

Explanation

## Diagnosis and Management of Enteric Fever in India ### Correct Answer Analysis **Key Point:** Fluoroquinolones are **NOT** first-line therapy anymore in India. Widespread resistance to fluoroquinolones (particularly in *Salmonella typhi* and *S. paratyphi*) has necessitated a shift to **third-generation cephalosporins** (ceftriaxone, cefixime) or **azithromycin** as empirical first-line agents. **High-Yield:** Current resistance patterns in India (2023): - Fluoroquinolone resistance: ~60–80% in many regions - Cephalosporin resistance: <5% (still reliable) - Azithromycin resistance: <10% (emerging) - Multidrug-resistant (MDR): ~40–50% ### Why the Other Options Are Correct | Statement | Explanation | |-----------|-------------| | **Blood culture sensitivity** | Highest in first week (~80–90%); sensitivity drops to ~40% by week 2 and ~10% by week 3 | | **Widal test limitations** | Poor specificity and sensitivity in endemic areas; baseline titers elevated; cannot differentiate acute from past infection | | **Bone marrow culture** | Gold standard with >90% sensitivity throughout illness; positive even when blood culture is negative | ### Treatment Algorithm ```mermaid flowchart TD A[Suspected Enteric Fever]:::outcome --> B{Severity?}:::decision B -->|Uncomplicated| C[Ceftriaxone or Cefixime]:::action B -->|Severe/Complicated| D[Ceftriaxone IV + Fluoroquinolone]:::action C --> E{Susceptibility known?}:::decision E -->|Yes| F[De-escalate if susceptible]:::action E -->|No| G[Continue cephalosporin]:::action D --> H[Switch to oral cephalosporin after improvement]:::action I[Avoid fluoroquinolone monotherapy]:::urgent ``` **Clinical Pearl:** In a febrile patient from an endemic area with positive blood culture, initiate **ceftriaxone 2 g IV BD** empirically while awaiting susceptibilities. Fluoroquinolones may be added for severe disease but should not be used alone. **Mnemonic:** **CAF** for enteric fever empirical therapy: - **C**ephalosporin (ceftriaxone, cefixime) — first-line - **A**zithromycin — alternative for uncomplicated - **F**luoroquinolone — adjunctive only, not monotherapy